| dc.description.abstract | Malaria remains a major global health problem due to the increasing resistance of
Plasmodium falciparum to currently available antimalarial drugs. Plasmodium
falciparum dihydroorotate dehydrogenase (PfDHODH), an essential enzyme in the
de novo pyrimidine biosynthesis pathway, has emerged as a promising target for
antimalarial drug discovery. This study aimed to evaluate the potential of five
chalcone derivatives as antimalarial candidates using an in silico approach. The
study employed molecular docking, binding pocket analysis, 200 ns molecular
dynamics simulation, and ADMET prediction. The molecular docking results
showed that all compounds occupied the same inhibitor binding pocket as the
reference ligand DSM705, with binding affinity values ranging from −7.7 to −9.7
kcal/mol, while the reference ligand exhibited −10.9 kcal/mol. Molecular dynamics
simulations demonstrated stable protein–ligand complexes based on protein
RMSD, ligand RMSD, and RMSF analyses. ADMET prediction indicated
favorable pharmacokinetic properties for all compounds, with Human Intestinal
Absorption values above 91%, while the SCH3 derivative exhibited the most
favorable toxicity profile. Overall, the five chalcone derivatives showed promising
potential as PfDHODH inhibitor-based antimalarial candidates. | en_US |